Login to Your Account

Genzyme Buying Clofarabine Partner In $345M Cash Deal

By Trista Morrison

Wednesday, May 30, 2007
With plans in place to expand clofarabine's label from pediatric acute lymphoblastic leukemia (ALL) to adult acute myeloid leukemia (AML), Genzyme Corp. moved to acquire partner Bioenvision Inc. in an all-cash deal worth approximately $345 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription